M&A Deal Summary

FUJIFILM Holdings Acquires Biogen - Biologics Manufacturing Site

On March 12, 2019, FUJIFILM Holdings acquired life science company Biogen - Biologics Manufacturing Site from Biogen for 890M USD

Acquisition Highlights
  • This is FUJIFILM Holdings’ 3rd transaction in the Life Science sector.
  • This is FUJIFILM Holdings’ 2nd largest (disclosed) transaction.
  • This is FUJIFILM Holdings’ 1st transaction in Denmark.

M&A Deal Summary
Date 2019-03-12
Target Biogen - Biologics Manufacturing Site
Sector Life Science
Buyer(s) FUJIFILM Holdings
Sellers(s) Biogen
Deal Type Divestiture
Deal Value 890M USD

Target

Biogen - Biologics Manufacturing Site

Hillerød, Denmark
Biogen (Denmark) Manufacturing ApS is a biologics manufacturing site. Hillerød site includes a 90,000L biologics production facility with assembly, labeling and packing capabilities, quality control laboratories and warehouses.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

FUJIFILM Holdings

Tokyo, Japan
Category Company
Founded 1934
Sector Electronics
Employees73,275
Revenue 2.96T JPY (2023)
DESCRIPTION

FUJIFILM Holdings is the holding company of the Fujifilm Group with three operating companies, FUJIFILM Corporation, Fuji Xerox Co., Ltd. and Toyama Chemical Co., Ltd. under its umbrella. Fujifilm develops products and services in fields ranging from film and photo-taking through to photo development and printing. FUJIFILM Holdings was founded in 1934 and is based in Tokyo, Japan.

DEAL STATS #
Overall 6 of 8
Sector (Life Science) 3 of 4
Type (Divestiture) 2 of 3
Country (Denmark) 1 of 1
Year (2019) 1 of 1
Size (of disclosed) 2 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-30 Cellular Dynamics International

Madison, Wisconsin, United States

Cellular Dynamics International, Inc. is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products).

Buy $307M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-20 Fuji Photo Film - Computed Radiography

Japan

Fuji Photo Film Co., Ltd. - Computed Radiography utilizes flexible phosphor imaging plates to capture high-resolution digital images.

Sell -

Seller(S) 1

SELLER

Biogen

Cambridge, Massachusetts, United States
Category Company
Founded 1978
Sector Life Science
Employees7,570
Revenue 9.8B USD (2023)
DESCRIPTION
Entrance to Biogen office in Weston, Massachusetts.
Entrance to Biogen office in Weston, Massachusetts.

Biogen is a biopharmaceutical company focused on discovering, developing, and delivering worldwide therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Biogen was founded in 1978 and is based in Cambridge, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Denmark) 1 of 1
Year (2019) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-03-04 Nightstar Therapeutics

London, United Kingdom

Nightstar Therapeutics plc is a clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. Nightstar Therapeutics plc was founded in 2013 and is based in London, United Kingdom.

Buy $877M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-13 Pfizer - CK 1 Business

New York, New York, United States

Pfizer, Inc. - CK 1 Business is a novel CNS-penetrant small molecule inhibitor of casein kinase 1 (CK1), for the potential treatment of patients with behavioral and neurological symptoms across various psychiatric and neurological diseases.

Buy $75M
Mergr

Product

Company

Legal